Minimally Invasive Decompression and Fusion Versus Open for Degenerative Lumbar Stenosis
Primary Purpose
Lumbar Spinal Stenosis, Intervertebral Disc Degeneration
Status
Recruiting
Phase
Not Applicable
Locations
Russian Federation
Study Type
Interventional
Intervention
lumbar fusion
Sponsored by
About this trial
This is an interventional diagnostic trial for Lumbar Spinal Stenosis
Eligibility Criteria
Inclusion Criteria:
- Age 40-75 years;
- Neurogenic claudication or bilateral radiculopathy caused by single level combination of degenerative stenosis and spondylolisthesis confirmed by MRI at one level L3-L4 or L4-L5 or L5-S1;
- Symptoms persisting for at least three months prior to surgery;
- Given written Informed Consent Form;
- Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements;
- Oswestry Disability Index score of at least 40/100 at baseline;
Exclusion Criteria:
- Bilateral foraminal stenosis requiring surgical decompression on both sides;
- Degenerative spondylolisthesis Type 2B, 3 subtypes by Gille;
- More than one symptomatic level requiring multi-level surgical decompression and/or fusion;
- Any condition that cannot be treated with mini-invasive unilateral decompression and fusion;
- Any contraindication or inability to undergo baseline and/or follow up MRI or X-ray as required per protocol;
- Spondylolisthesis grade II or higher of any etiology;
- Prior lumbar spinal fusion at any level;
- Other non-degenerative spinal conditions that may have an impact on subject safety, wellbeing or the intent and conduct of the study;
- History or presence of any other major neurological disease or condition that may interfere with the study assessments;
- Severe arterial insufficiency of the legs or other peripheral vascular disease;
- Previous enrollment in this study, current enrollment or plans to be enrolled in another study (in parallel to this study).
Sites / Locations
- Priorov National Medical Research Center of Traumatology and OrthopedicsRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Minimally invasive TLIF
Open TLIF
Arm Description
Patients will undergo a single level decompression and fusion using a minimally invasive technique. Followed posterior screw fixation is mandatory.
Patients will undergo a single level decompression and fusion using an open traditional technique. Followed posterior screw fixation is mandatory.
Outcomes
Primary Outcome Measures
Change from baseline in Oswestry Disability Index (ODI)
To observe the change of ODI as compared to baseline through follow-up terms. min - 0, - the best result, patient is active; max - 50 - the worst result, patient is not physically active
Secondary Outcome Measures
Change from baseline in Oswestry Disability Index (ODI)
To observe the change of ODI as compared to baseline through follow-up terms. min - 0, - the best result, patient is active; max - 50 - the worst result, patient is not physically active
Change from baseline in Numeric Pain Rating Score (NPRS)
To observe the change of NPRS as compared to baseline through follow-up terms (0 - no pain, 10 - unbearable pain)
Change from baseline in EuroQol Five-Dimensional descriptive system questionnaire (EQ-5D).
To observe the change of EQ-5D as compared to baseline through follow-up terms. It assesses 5 components related to aspects of life: mobility, self-care, activity in daily life, pain, anxiety or depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.
Change from baseline in Douleur Neuropathique 4 (DN4)
To observe the change of DN4 as compared to baseline through follow-up terms. The scale result ranges 0-10 points. The sum > 4 points indicates the neuropathic component of pain
Change from baseline in The Health Transition Item from SF-36 (HTI Item)
To observe the change of HTI Item through follow-up terms. Patient's answers range from ''Much Better,'' ''Somewhat Better,'' ''About the Same,'' ''Somewhat Worse,'' to ''Much Worse.''
Change from baseline in Clinical Global Impression Of Change (CGIC) scale
To observe the change of CGIC through follow-up terms. The answers range from "-2 Significantly worse compared to Baseline" to "+2 Significantly improved compared to Baseline". 7-points scale indicates the patient's condition assessed by physician.
Cost-effectiveness
Total cost of surgical procedure (implanted system, the salary for surgery team) and the cost of patient's staying at the clinic before discharge.
Fusion rate success
Interbody fusion rate on CT based on Tan grades
Surgery duration
Surgery duration, min
Reoperations rate
Incidence of reoperations
Pelvic Incidence
To observe the sagittal balance parameter - Pelvic Incidence - by sagittal scans of spine by X-Ray, in degrees
Change from baseline in Pelvic Tilt
To observe the sagittal balance parameter - Pelvic Tilt - by sagittal scans of spine by X-Ray compared to baseline, in degrees
Change from baseline in Global Lordosis Angle
To observe the sagittal balance parameter - Global Lordosis Angle - by sagittal scans of spine by X-Ray compared to baseline, in degrees
Change from baseline in Segmental Lordosis
To observe the sagittal balance parameter - Segmental Lordosis (the angle of treated level) - by sagittal scans of spine by X-Ray compared to baseline, in degrees
Change from baseline in Sagittal Vertical Axis
To observe the sagittal balance parameter - Sagittal Vertical Axis - by sagittal scans of spine by X-Ray compared to baseline, in mm
Adverse Events
Document Adverse Events (incl. adverse events related to device) occurrence throughout the study
Full Information
NCT ID
NCT04594980
First Posted
October 10, 2020
Last Updated
October 24, 2023
Sponsor
N.N. Priorov National Medical Research Center of Traumatology and Orthopedics
1. Study Identification
Unique Protocol Identification Number
NCT04594980
Brief Title
Minimally Invasive Decompression and Fusion Versus Open for Degenerative Lumbar Stenosis
Official Title
An Open-Label Randomized Controlled Study of the Efficacy of Surgical Treatment in Patients With Single Level Lumbar Spinal Stenosis Using Minimally Invasive Decompression and Fusion and Traditional Open
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 20, 2022 (Actual)
Primary Completion Date
February 10, 2024 (Anticipated)
Study Completion Date
February 1, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
N.N. Priorov National Medical Research Center of Traumatology and Orthopedics
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The purpose of this study is to determine the effectiveness of minimally invasive decompression and fusion over the traditional open decompression and fusion in patients with single-level lumbar stenosis caused by degenerative spondylolisthesis. Postoperative follow-up will continue for 12 months. Сlinical, safety, radiological and cost-effectiveness endpoints will be evaluated.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lumbar Spinal Stenosis, Intervertebral Disc Degeneration
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
96 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Minimally invasive TLIF
Arm Type
Other
Arm Description
Patients will undergo a single level decompression and fusion using a minimally invasive technique. Followed posterior screw fixation is mandatory.
Arm Title
Open TLIF
Arm Type
Other
Arm Description
Patients will undergo a single level decompression and fusion using an open traditional technique. Followed posterior screw fixation is mandatory.
Intervention Type
Procedure
Intervention Name(s)
lumbar fusion
Intervention Description
Transforaminal Lumbar Interbody Fusion will be performed using minimally invasive approach or traditional open technique.
Primary Outcome Measure Information:
Title
Change from baseline in Oswestry Disability Index (ODI)
Description
To observe the change of ODI as compared to baseline through follow-up terms. min - 0, - the best result, patient is active; max - 50 - the worst result, patient is not physically active
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Change from baseline in Oswestry Disability Index (ODI)
Description
To observe the change of ODI as compared to baseline through follow-up terms. min - 0, - the best result, patient is active; max - 50 - the worst result, patient is not physically active
Time Frame
Through 2 years
Title
Change from baseline in Numeric Pain Rating Score (NPRS)
Description
To observe the change of NPRS as compared to baseline through follow-up terms (0 - no pain, 10 - unbearable pain)
Time Frame
Through 2 years
Title
Change from baseline in EuroQol Five-Dimensional descriptive system questionnaire (EQ-5D).
Description
To observe the change of EQ-5D as compared to baseline through follow-up terms. It assesses 5 components related to aspects of life: mobility, self-care, activity in daily life, pain, anxiety or depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.
Time Frame
Through 2 years
Title
Change from baseline in Douleur Neuropathique 4 (DN4)
Description
To observe the change of DN4 as compared to baseline through follow-up terms. The scale result ranges 0-10 points. The sum > 4 points indicates the neuropathic component of pain
Time Frame
Through 2 years
Title
Change from baseline in The Health Transition Item from SF-36 (HTI Item)
Description
To observe the change of HTI Item through follow-up terms. Patient's answers range from ''Much Better,'' ''Somewhat Better,'' ''About the Same,'' ''Somewhat Worse,'' to ''Much Worse.''
Time Frame
Through 2 years
Title
Change from baseline in Clinical Global Impression Of Change (CGIC) scale
Description
To observe the change of CGIC through follow-up terms. The answers range from "-2 Significantly worse compared to Baseline" to "+2 Significantly improved compared to Baseline". 7-points scale indicates the patient's condition assessed by physician.
Time Frame
Through 2 years
Title
Cost-effectiveness
Description
Total cost of surgical procedure (implanted system, the salary for surgery team) and the cost of patient's staying at the clinic before discharge.
Time Frame
14th day of hospital stay
Title
Fusion rate success
Description
Interbody fusion rate on CT based on Tan grades
Time Frame
12 months and 24 months post op
Title
Surgery duration
Description
Surgery duration, min
Time Frame
Day of surgery
Title
Reoperations rate
Description
Incidence of reoperations
Time Frame
Through 2 years
Title
Pelvic Incidence
Description
To observe the sagittal balance parameter - Pelvic Incidence - by sagittal scans of spine by X-Ray, in degrees
Time Frame
Through 2 years
Title
Change from baseline in Pelvic Tilt
Description
To observe the sagittal balance parameter - Pelvic Tilt - by sagittal scans of spine by X-Ray compared to baseline, in degrees
Time Frame
Through 2 years
Title
Change from baseline in Global Lordosis Angle
Description
To observe the sagittal balance parameter - Global Lordosis Angle - by sagittal scans of spine by X-Ray compared to baseline, in degrees
Time Frame
Through 2 years
Title
Change from baseline in Segmental Lordosis
Description
To observe the sagittal balance parameter - Segmental Lordosis (the angle of treated level) - by sagittal scans of spine by X-Ray compared to baseline, in degrees
Time Frame
Through 2 years
Title
Change from baseline in Sagittal Vertical Axis
Description
To observe the sagittal balance parameter - Sagittal Vertical Axis - by sagittal scans of spine by X-Ray compared to baseline, in mm
Time Frame
Through 2 years
Title
Adverse Events
Description
Document Adverse Events (incl. adverse events related to device) occurrence throughout the study
Time Frame
Through 2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 40-75 years;
Neurogenic claudication or bilateral radiculopathy caused by single level combination of degenerative stenosis and spondylolisthesis confirmed by MRI at one level L3-L4 or L4-L5 or L5-S1;
Symptoms persisting for at least three months prior to surgery;
Given written Informed Consent Form;
Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements;
Oswestry Disability Index score of at least 40/100 at baseline;
Exclusion Criteria:
Bilateral foraminal stenosis requiring surgical decompression on both sides;
Degenerative spondylolisthesis Type 2B, 3 subtypes by Gille;
More than one symptomatic level requiring multi-level surgical decompression and/or fusion;
Any condition that cannot be treated with mini-invasive unilateral decompression and fusion;
Any contraindication or inability to undergo baseline and/or follow up MRI or X-ray as required per protocol;
Spondylolisthesis grade II or higher of any etiology;
Prior lumbar spinal fusion at any level;
Other non-degenerative spinal conditions that may have an impact on subject safety, wellbeing or the intent and conduct of the study;
History or presence of any other major neurological disease or condition that may interfere with the study assessments;
Severe arterial insufficiency of the legs or other peripheral vascular disease;
Previous enrollment in this study, current enrollment or plans to be enrolled in another study (in parallel to this study).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Aleksandr Krutko, MD, PhD
Phone
+79139189603
Email
ortho-ped@mail.ru
Facility Information:
Facility Name
Priorov National Medical Research Center of Traumatology and Orthopedics
City
Moscow
ZIP/Postal Code
127299
Country
Russian Federation
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aleksandr Krutko
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Data are available upon reasonable request. Please contact the corresponding author for detail.
IPD Sharing Time Frame
During the study conducting and during 5 years after
IPD Sharing Access Criteria
The approval of institutional review board will be necessary
Citations:
PubMed Identifier
33674366
Citation
Leonova ON, Cherepanov EA, Krutko AV. MIS-TLIF versus O-TLIF for single-level degenerative stenosis: study protocol for randomised controlled trial. BMJ Open. 2021 Mar 5;11(3):e041134. doi: 10.1136/bmjopen-2020-041134.
Results Reference
derived
Learn more about this trial
Minimally Invasive Decompression and Fusion Versus Open for Degenerative Lumbar Stenosis
We'll reach out to this number within 24 hrs